153 related articles for article (PubMed ID: 31899801)
1. GRK6 regulates the hemostatic response to injury through its rate-limiting effects on GPCR signaling in platelets.
Chen X; Gupta S; Cooper M; DeHelian D; Zhao X; Naik MU; Wurtzel JGT; Stalker TJ; Goldfinger LE; Benovic J; Brass LF; McKenzie SE; Naik UP; Ma P
Blood Adv; 2020 Jan; 4(1):76-86. PubMed ID: 31899801
[TBL] [Abstract][Full Text] [Related]
2. Role of GRK6 in the Regulation of Platelet Activation through Selective G Protein-Coupled Receptor (GPCR) Desensitization.
Chaudhary PK; Kim S; Jee Y; Lee SH; Park KM; Kim S
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32486261
[TBL] [Abstract][Full Text] [Related]
3. Biphasic kinetics of activation and signaling for PAR1 and PAR4 thrombin receptors in platelets.
Covic L; Gresser AL; Kuliopulos A
Biochemistry; 2000 May; 39(18):5458-67. PubMed ID: 10820018
[TBL] [Abstract][Full Text] [Related]
4. Protease-activated receptors 1 and 4 do not stimulate G(i) signaling pathways in the absence of secreted ADP and cause human platelet aggregation independently of G(i) signaling.
Kim S; Foster C; Lecchi A; Quinton TM; Prosser DM; Jin J; Cattaneo M; Kunapuli SP
Blood; 2002 May; 99(10):3629-36. PubMed ID: 11986217
[TBL] [Abstract][Full Text] [Related]
5. RGS10 shapes the hemostatic response to injury through its differential effects on intracellular signaling by platelet agonists.
Ma P; Gupta S; Sampietro S; DeHelian D; Tutwiler V; Tang A; Stalker TJ; Brass LF
Blood Adv; 2018 Aug; 2(16):2145-2155. PubMed ID: 30150297
[TBL] [Abstract][Full Text] [Related]
6. The ATP-gated P2X1 receptor plays a pivotal role in activation of aspirin-treated platelets by thrombin and epinephrine.
Grenegård M; Vretenbrant-Oberg K; Nylander M; Désilets S; Lindström EG; Larsson A; Ramström I; Ramström S; Lindahl TL
J Biol Chem; 2008 Jul; 283(27):18493-504. PubMed ID: 18480058
[TBL] [Abstract][Full Text] [Related]
7. PAR4-Mediated PI3K/Akt and RhoA/ROCK Signaling Pathways Are Essential for Thrombin-Induced Morphological Changes in MEG-01 Cells.
Heo Y; Jeon H; Namkung W
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054966
[TBL] [Abstract][Full Text] [Related]
8. Genetic deletion of platelet PAR4 results in reduced thrombosis and impaired hemostatic plug stability.
Lee RH; Kawano T; Grover SP; Bharathi V; Martinez D; Cowley DO; Mackman N; Bergmeier W; Antoniak S
J Thromb Haemost; 2022 Feb; 20(2):422-433. PubMed ID: 34689407
[TBL] [Abstract][Full Text] [Related]
9. GRK2 regulates ADP signaling in platelets via P2Y1 and P2Y12.
Zhao X; Cooper M; Michael JV; Yarman Y; Baltz A; Chuprun JK; Koch WJ; McKenzie SE; Tomaiuolo M; Stalker TJ; Zhu L; Ma P
Blood Adv; 2022 Aug; 6(15):4524-4536. PubMed ID: 35793439
[TBL] [Abstract][Full Text] [Related]
10. Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin.
Kahn ML; Nakanishi-Matsui M; Shapiro MJ; Ishihara H; Coughlin SR
J Clin Invest; 1999 Mar; 103(6):879-87. PubMed ID: 10079109
[TBL] [Abstract][Full Text] [Related]
11. Antithrombotic effects of PAR1 and PAR4 antagonists evaluated under flow and static conditions.
Hosokawa K; Ohnishi T; Miura N; Sameshima H; Koide T; Tanaka KA; Maruyama I
Thromb Res; 2014 Jan; 133(1):66-72. PubMed ID: 24268424
[TBL] [Abstract][Full Text] [Related]
12. Regulation of protease-activated receptor (PAR) 1 and PAR4 signaling in human platelets by compartmentalized cyclic nucleotide actions.
Bilodeau ML; Hamm HE
J Pharmacol Exp Ther; 2007 Aug; 322(2):778-88. PubMed ID: 17525299
[TBL] [Abstract][Full Text] [Related]
13. Protease-activating receptor-4 induces full platelet spreading on a fibrinogen matrix: involvement of ERK2 and p38 and Ca2+ mobilization.
Mazharian A; Roger S; Berrou E; Adam F; Kauskot A; Nurden P; Jandrot-Perrus M; Bryckaert M
J Biol Chem; 2007 Feb; 282(8):5478-87. PubMed ID: 17200114
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the distinct mechanism of agonist-induced canine platelet activation.
Chaudhary PK; Kim S
J Vet Sci; 2019 Jan; 20(1):10-15. PubMed ID: 30541187
[TBL] [Abstract][Full Text] [Related]
15. The Roles of GRKs in Hemostasis and Thrombosis.
Chen X; Zhao X; Cooper M; Ma P
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32731360
[TBL] [Abstract][Full Text] [Related]
16. Cathepsin G activates protease-activated receptor-4 in human platelets.
Sambrano GR; Huang W; Faruqi T; Mahrus S; Craik C; Coughlin SR
J Biol Chem; 2000 Mar; 275(10):6819-23. PubMed ID: 10702240
[TBL] [Abstract][Full Text] [Related]
17. Thrombin induces platelet activation in the absence of functional protease activated receptors 1 and 4 and glycoprotein Ib-IX-V.
Lova P; Canobbio I; Guidetti GF; Balduini C; Torti M
Cell Signal; 2010 Nov; 22(11):1681-7. PubMed ID: 20600849
[TBL] [Abstract][Full Text] [Related]
18. Role of Galphaq and phospholipase C-beta2 in human platelets activation by thrombin receptors PAR1 and PAR4: studies in human platelets deficient in Galphaq and phospholipase C-beta2.
Vaidyula VR; Rao AK
Br J Haematol; 2003 May; 121(3):491-6. PubMed ID: 12716374
[TBL] [Abstract][Full Text] [Related]
19. The protein tyrosine phosphatase PTPN7 is a negative regulator of ERK activation and thromboxane generation in platelets.
Inamdar VV; Reddy H; Dangelmaier C; Kostyak JC; Kunapuli SP
J Biol Chem; 2019 Aug; 294(33):12547-12554. PubMed ID: 31266805
[TBL] [Abstract][Full Text] [Related]
20. Signaling through G(alpha)13 switch region I is essential for protease-activated receptor 1-mediated human platelet shape change, aggregation, and secretion.
Huang JS; Dong L; Kozasa T; Le Breton GC
J Biol Chem; 2007 Apr; 282(14):10210-22. PubMed ID: 17298951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
